Nā huahana
-
HIV 1/2 Antibody
Hoʻohana ʻia ka kit no ka ʻike qualitative o ke kanaka immunodeficiency virus (HIV1/2) antibody i ke koko holoʻokoʻa o ke kanaka, serum a me ka plasma.
-
15 Nā ʻano o ke kanaka Papillomavirus E6/E7 Gene mRNA
Kuhi ʻia kēia pahu i ka ʻike kūpono o 15 mau kiʻekiʻe kiʻekiʻe o ka papillomavirus kanaka (HPV) E6/E7 gene mRNA hōʻike pae i loko o nā cell exfoliated o ka pūpū wahine.
-
28 Nā ʻano o ka maʻi maʻi papilloma kanaka kiʻekiʻe (16/18 paʻi) ʻakika nucleic
He kūpono kēia pahu no ka ʻike in vitro qualitative o 28 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 53, 52, 53 61, 66, 68, 73, 81, 82, 83) ʻakika nucleic i loko o ka mimi kāne/wahine a me nā pūnaeho exfoliated cervical wahine. Hiki ke paʻi ʻia ka HPV 16/18, ʻaʻole hiki ke paʻi piha ʻia nā ʻano i koe, e hāʻawi ana i mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
28 Nā ʻano o ka HPV Nucleic Acid
Hoʻohana ʻia ka pahu no ka ʻike in vitro qualitative o 28 mau ʻano papillomaviruses kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 5, 6 66, 68, 73, 81, 82, 83) ʻakika nucleic i loko o ka mimi kāne / wahine a me nā pūnaewele cervical exfoliated wahine, akā ʻaʻole hiki ke paʻi piha ʻia ka maʻi.
-
Human Papillomavirus (28 ʻAno) Genotyping
Hoʻohana ʻia kēia pahu no ka ʻike qualitative a me ka genotyping o ka waikawa nucleic o 28 mau ʻano o ka papillomavirus kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 55, 5, 5, 5, 5, 5, 5 61, 66, 68, 73, 81, 82, 83) i loko o ka mimi kāne/kane a me ka wahine cervical exfoliated cell, e hāʻawi ana i nā mea kōkua no ka hōʻoia a me ka mālama ʻana i ka maʻi HPV.
-
ʻO Enterococcus kū'ē iā Vancomycin a me Gene kū'ē i ka lāʻau
Hoʻohana ʻia kēia kit no ka ʻike qualitative o vancomycin-resistant enterococcus (VRE) a me kāna mau genes kūʻē i ka lāʻau VanA a me VanB i loko o ka sputum kanaka, koko, mimi a i ʻole nā kolone maʻemaʻe.
-
ʻO ke kanaka CYP2C9 a me VKORC1 Gene Polymorphism
Pili kēia kit i ka in vitro qualitative detection of polymorphism o CYP2C9*3 (rs1057910, 1075A>C) a me VKORC1 (rs9923231, -1639G>A) i loko o ka genomic DNA o ke kanaka holookoa koko samples.
-
Kanaka CYP2C19 Gene Polymorphism
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka polymorphism o CYP2C19 genes CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*248 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C12*248 (rs. DNA genomic o ke koko holookoa kanaka.
-
Kanaka Leukocyte Antigen B27 Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka DNA i nā subtypes antigen leukocyte kanaka HLA-B*2702, HLA-B*2704 a me HLA-B*2705.
-
Monkeypox Virus Nucleic Acid
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka monkeypox virus nucleic acid i loko o ka wai ʻūhū kanaka, nā nasopharyngeal swabs, nā ʻāʻī a me nā laʻana serum.
-
Fecal Occult Blood/Transferrin Hui
He mea kūpono kēia kit no ka ʻike in vitro qualitative o Human hemoglobin (Hb) a me Transferrin (Tf) i loko o nā laʻana kuʻekuʻe kanaka, a hoʻohana ʻia no ka ʻike kōkua o ke kahe ʻana o ka digestive tract.
-
Ureaplasma Urealycum Nucleic Acid
He kūpono kēia pahu no ka ʻike qualitative o Ureaplasma urealyticum (UU) i loko o ka ʻāpana mimi kāne a me nā ʻāpana huna huna wahine i loko o ka vitro.
